Literature DB >> 19694319

Myoid hamartoma of breast with chondroid metaplasia: a case report.

Joon Joon Khoo1, Rizal-Imran Alwi, Iratina Abd-Rahman.   

Abstract

Breast hamartoma is an uncommon poorly recognised benign breast neoplasm. Hamartoma displaying marked smooth muscle components known as myoid hamartoma of the breast is a much rarer entity. We present a case of myoid hamartoma of breast with chondroid differentiation in a 46-year-old woman. The painless breast lump was circumscribed and mammography showed a well-encapsulated large, dense mass with no calcification. Core needle biopsy was reported as fibroadenoma. The lesion was excised. Microscopically, it composed of many groups of mammary glandular components with dense fibrous stroma, adipose tissue and marked groups of smooth muscle fibres. Foci of chondroid differentiation were noted in the lesion. The smooth muscle cells showed strong and diffuse immunoreactivity for vimentin, myogloblin, alpha-smooth muscle actin, desmin and CD34 and failed to express pan-cytokeratin or S100 protein. The ducts lined by epithelial cells were reactive to pan-cytokeratin while the myoepithelial cells were reactive to S100 protein. The various immuno-histochemical staining as well as the cyto-histological changes encountered in myoid hamartomas are discussed with clinical, radiological and pathological correlation to differentiate it from other benign and malignant breast lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19694319

Source DB:  PubMed          Journal:  Malays J Pathol        ISSN: 0126-8635            Impact factor:   0.656


  6 in total

1.  Myoid hamartoma of the breast that proved difficult to diagnose: a case report.

Authors:  Naruhiko Mizuta; Koichi Sakaguchi; Mitsuhiko Mizuta; Aya Imai; Katsuhiko Nakatsukasa; Midori Morita; Mari Soshi; Mariko Goto; Satoru Yasukawa; Eiichi Konishi; Tetsuya Taguchi
Journal:  World J Surg Oncol       Date:  2012-01-16       Impact factor: 2.754

2.  Breast Hamartoma: Clinical, Radiological, and Histopathological Evaluation.

Authors:  Deniz Tazeoğlu; Ahmet Dağ; Bilal Arslan; Mustafa Berkeşoğlu
Journal:  Eur J Breast Health       Date:  2021-10-04

3.  Chromosomal Translocation t(5;12)(p13;q14) Leading to Fusion of High-mobility Group AT-hook 2 Gene With Intergenic Sequences From Chromosome Sub-Band 5p13.2 in Benign Myoid Neoplasms of the Breast: A Second Case.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Kristin Andersen; Marius Lund-Iversen; Hanne Regine Hognestad; Ingvild Lobmaier; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2022 Jul-Aug       Impact factor: 3.395

4.  Genetic Characterization of Myoid Hamartoma of the Breast.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Hege Kilen Andersen; Thomas Dahl Pedersen; Jon Lømo; Marius Lund-Iversen; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

5.  Myoid hamartoma of the breast with focal chondromyoxid metaplasia and pseudoangiomatous stromal hyperplasia: A case report.

Authors:  Chin-Cheng Su; Chih-Jung Chen; Shou-Jen Kuo; Dar-Ren Chen
Journal:  Oncol Lett       Date:  2015-01-23       Impact factor: 2.967

Review 6.  Breast hamartoma: a clinicopathologic analysis of 27 cases and a literature review.

Authors:  Yusuf Sevim; Akin Firat Kocaay; Tevfik Eker; Haydar Celasin; Ayca Karabork; Esra Erden; Volkan Genc
Journal:  Clinics (Sao Paulo)       Date:  2014-08       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.